Category: LIVMARLI
-
Mirum Pharmaceuticals’ LIVMARLI Data Showcased at ESPGHAN Annual Meeting By Investing.com
•
– Seven summaries highlighting ALGS and PFIC data, including three oral presentations – Long-term extension data from the phase III PFIC study were presented in plenary and selected from among the highest-scoring abstracts FOSTER CITY, Calif.–( BUSINESS WIRE )–Mirom Pharmaceuticals (Nasdaq: MIRM) today announced data presented at the 56th Annual…